Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ME2 | P23368 | 1/20 | 0.70 |
| ▸ | ME1 | P48163 | 1/20 | 0.70 |
| ▸ | ME3 | Q16798 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 6/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 3/20 | 0.65 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | LDHA | P00338 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535489 | 0.88 | CYP2D6 (0.60) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL9624322 | 0.88 | POLB (0.59) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL5375009 | 0.85 | MEN1 (0.60) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL31401681 | 0.85 | MEN1 (0.70) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL30354048 | 0.85 | MEN1 (0.70) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL28652 | 0.85 | MEN1 (0.70) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL3391301 | 0.85 | POLB (0.69) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL8470674 | 0.83 | ME2 (1.00) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL29779946 | 0.83 | CYP1A2 (0.68) | ME2ME1ME3MEN1KMT2A | |
| SCHEMBL88986 | 0.83 | CYP1A2 (0.68) | ME2ME1ME3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | claimed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | claimed |
| US-9149019-B2 | Method of eliminating cat urine odor | JMR, LC (US) | 2015-10-06 | — | — | US | disclosed |
| US-20130323194-A1 | METHOD OF ELIMINATING CAT URINE ODOR | CO2 TECHNOLOGIES, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |
| US-20070066170-A1 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2007-03-22 | — | — | US | disclosed |
| US-7189666-B2 | CO2 generating absorbent pads | CO2 TECHNOLOGIES (US) | 2007-03-13 | — | — | US | disclosed |
| US-7160939-B2 | Preservatives; mixture of carbon dioxide in polymer matrix; mixture containing citric acid, calcium carbonate and low density polyethylene | CO2 TECHNOLOGIES, INC. | 2007-01-09 | — | — | US | disclosed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | disclosed |
| US-20050001204-A1 | Active masterbatch for production of CO2 generating masterbatch | CO2 TECHNOLOGIES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004110876-A2 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040247750-A1 | CO2 generating absorbent pads | CO2 TECHNOLOGIES, INC. | 2004-12-09 | — | — | US | disclosed |
| US-6797235-B2 | Device and methods for modifying an atmosphere | CO2 TECHNOLOGIES, INC. | 2004-09-28 | — | — | US | disclosed |
| WO-2004022112-A1 | DEVICE AND METHODS FOR MODIFYING AN ATMOSPHERE | CO2 TECHNOLOGIES, INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20040047760-A1 | Device and methods for modifying an atmosphere | LONGER SHELF LIFE, LLC | 2004-03-11 | — | — | US | disclosed |
| EP-0921855-A1 | ISOLATION OF IMMUNOGLOBULINS | UPFRONT CHROMATOGRAPHY A/S (DK) | 1999-06-16 | — | — | EP | disclosed |
| WO-1998008603-A1 | ISOLATION OF IMMUNOGLOBULINS | UPFRONT CHROMATOGRAPHY A/S (DK) | 1998-03-05 | — | — | WO | disclosed |
| US-4329494-A | Recycling techniques in the production of 6-hydroxy-2-naphthoic acid | AMERICAN CYANAMID COMPANY (US) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111582-A1 | Process for arylamine production | AOC2, UFM1, TYR | ME2 3432/4885ME1 3088/4885ME3 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.